Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 1,009: | Line 1,009: | ||
"title" : "Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years", | "title" : "Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years", | ||
"pmid" : "30699314" | "pmid" : "30699314" | ||
}, | |||
{ | |||
"timestamp" : "2025-01-30T19:13:30Z", | |||
"briefDesignDescription" : "Apixaban vs. aspirin in subclinical AF", | |||
"fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa2310234", | |||
"pageid" : 5604, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2310234", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Healey JS, <i>et al</i>. \"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2023. 390(2):107-117.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Apixaban for the Reduction of Thromboembolism in Patients with Device-Detected Subclinical Atrial Fibrillation", | |||
"statusUsableDate" : "2025-01-30", | |||
"briefResultsDescription" : "Apixaban reduced stroke, but increased major bleeding", | |||
"published" : "2023-11-12", | |||
"pageName" : "ARTESIA", | |||
"diseases" : "Atrial Fibrillation", | |||
"abbreviation" : "ARTESIA", | |||
"title" : "Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation", | |||
"pmid" : "37952132" | |||
}, | }, | ||
{ | { | ||
Line 6,215: | Line 6,234: | ||
"title" : "Oral versus Intravenous Antibiotics for Bone and Joint Infection", | "title" : "Oral versus Intravenous Antibiotics for Bone and Joint Infection", | ||
"pmid" : "30699315" | "pmid" : "30699315" | ||
}, | |||
{ | |||
"timestamp" : "2025-01-30T20:34:51Z", | |||
"briefDesignDescription" : "Penicillin allergy rule-out", | |||
"fulltexturl" : "https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2806976", | |||
"pageid" : 5406, | |||
"pdfurl" : "https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2806976/jamainternal_copaescu_2023_oi_230043_1693517098.10841.pdf", | |||
"trainingLevel" : "student", | |||
"citation" : "Copaescu AM, <i>et al</i>. \"Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy\". <i>JAMA Internal Med</i>. 2023. 183(9):944-952.", | |||
"subspecialties" : "Infectious Disease", | |||
"expansion" : "The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge", | |||
"statusUsableDate" : "2025-01-29", | |||
"briefResultsDescription" : "Penicillin 1-step rule out noninferior to 2-step", | |||
"published" : "2023-09-01", | |||
"pageName" : "PALACE", | |||
"diseases" : "Penicillin Allergy", | |||
"abbreviation" : "PALACE", | |||
"title" : "Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy", | |||
"pmid" : "37459086" | |||
}, | }, | ||
{ | { |